Pentixapharm Holding AG
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pentixapharm Holding AG
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.
/ 
Frequently asked questions
To buy Pentixapharm Holding AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pentixapharm Holding AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pentixapharm Holding AG is PTP:xetr. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pentixapharm Holding AG has its primary listing on Deutsche Börse (XETRA). You can trade Pentixapharm Holding AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pentixapharm Holding AG is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Pentixapharm Holding AG as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Pentixapharm Holding AG or others.